Gautam Gare

Jia Shi, Gautam Gare, Jinjin Tian et al.

We tackle the challenge of predicting models' Out-of-Distribution (OOD) performance using in-distribution (ID) measurements without requiring OOD data. Existing evaluations with "Effective Robustness", which use ID accuracy as an indicator of OOD accuracy, encounter limitations when models are trained with diverse supervision and distributions, such as class labels (Vision Models, VMs, on ImageNet) and textual descriptions (Visual-Language Models, VLMs, on LAION). VLMs often generalize better to OOD data than VMs despite having similar or lower ID performance. To improve the prediction of models' OOD performance from ID measurements, we introduce the Lowest Common Ancestor (LCA)-on-the-Line framework. This approach revisits the established concept of LCA distance, which measures the hierarchical distance between labels and predictions within a predefined class hierarchy, such as WordNet. We assess 75 models using ImageNet as the ID dataset and five significantly shifted OOD variants, uncovering a strong linear correlation between ID LCA distance and OOD top-1 accuracy. Our method provides a compelling alternative for understanding why VLMs tend to generalize better. Additionally, we propose a technique to construct a taxonomic hierarchy on any dataset using K-means clustering, demonstrating that LCA distance is robust to the constructed taxonomic hierarchy. Moreover, we demonstrate that aligning model predictions with class taxonomies, through soft labels or prompt engineering, can enhance model generalization. Open source code in our Project Page: https://elvishelvis.github.io/papers/lca/.

Gautam Gare, John Galeotti, Michael Mozer et al.

In nature, events that affect some individuals or groups but not others constitute an implicit intervention and are known as natural experiments. For example, the COVID-19 pandemic was an intervention by the coronavirus on the sub-population infected with COVID. We ask, do natural experiments occur in existing real-world datasets? If yes, how should we treat them? To detect natural experiments in data, we use causal discovery to recover the underlying causal graph and perform feature selection based on causal links. If downstream performance improves by treating the data as interventional rather than observational, we argue that this suggests the dataset contains natural experiments. We first validate this hypothesis by simulating datasets with and without natural experiments using synthetic graphs. We then perform a systematic empirical evaluation on a large suite of real-world datasets. Our results indicate that real-world datasets do contain natural experiments and we can take advantage of those natural experiments to improve model performance using causal inference. Our work represents the initial foray into this area, offering a preliminary exploration within a limited scope.

Jana Armouti, Laura Hutchins, Jacob Duplantis et al.

Hospital readmission within 30 days of discharge is a leading driver of morbidity, mortality, and avoidable healthcare expenditure in congestive heart failure (CHF). Current clinical risk stratification tools rely primarily on non-imaging data and exhibit limited predictive performance. Point-of-care lung ultrasound (LUS) offers a sensitive, noninvasive window into the pulmonary congestion that characterizes CHF decompensation, yet its prognostic utility for readmission prediction remains largely unexplored. We present a pilot feasibility study, the first systematic machine learning study using B-mode LUS acquired during hospitalization to predict 30-day CHF readmission. Quantitative spatiotemporal embeddings are extracted from a pretrained Temporal Shift Module (TSM) ResNet-18 encoder, and interpretable biomarker features are separately evaluated. Through structured ablations over lung view, temporal representation, multi-view fusion, and cross-lung augmentation, we identify the key imaging factors driving readmission risk. Our findings reveal that (1) dependent lower-lung regions (Left-3, Right-3) carry the strongest prognostic signal, consistent with their greater susceptibility to hydrostatic congestion; (2) temporal difference features between sequential examinations substantially outperform single-timepoint representations, highlighting the importance of capturing disease trajectory; and (3) multi-view feature concatenation yields the best overall performance, with our top MLP model achieving an F1 score of 0.80 (95% CI: 0.62-0.96). Biomarker analysis further reveals that pleural-line abnormalities, including breaks and indentations, are as informative as the canonical A-line and B-line markers. These results support POCUS-derived biomarkers as practical, interpretable tools for noninvasive CHF risk stratification.

Jana Armouti, Nikhil Madaan, Rohan Panda et al. · cmu

Predicting whether a treatment leads to meaningful improvement is a central challenge in personalized medicine, particularly when disease progression manifests as subtle visual changes over time. While data-driven deep learning (DL) offers a promising route to automate such predictions, acquiring large-scale longitudinal data for each individual patient remains impractical. To address this limitation, we explore whether inter-patient variability can serve as a proxy for learning intra-patient progression. We propose LEARNER, a contrastive pretraining framework that leverages coarsely labeled inter-patient data to learn fine-grained, patient-specific representations. Using lung ultrasound (LUS) and brain MRI datasets, we demonstrate that contrastive objectives trained on coarse inter-patient differences enable models to capture subtle intra-patient changes associated with treatment response. Across both modalities, our approach improves downstream classification accuracy and F1-score compared to standard MSE pretraining, highlighting the potential of inter-patient contrastive learning for individualized outcome prediction.